Oxytocin receptor

Agonist-induced localization in lipid raft increases or inhibits cell proliferation 2, 3

• 1. [362] Gimpl, G, Fahrenholz F.  2000.  Human oxytocin receptors in cholesterol-rich vs. cholesterol-poor microdomains of the plasma membrane. Eur J Biochem. 267:2483-97.
• 2. a. b. [367] Guzzi, F, Zanchetta D, Cassoni P, Guzzi V, Francolini M, Parenti M, Chini B.  2002.  Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response. Oncogene. 21:1658-67.
• 3. [437] Whittington, K, Connors B, King K, Assinder S, Hogarth K, Nicholson H.  2007.  The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate. Prostate. 67:1132-42.

Bound caveolin-2 2

• 1. a. b. c. [362] Gimpl, G, Fahrenholz F.  2000.  Human oxytocin receptors in cholesterol-rich vs. cholesterol-poor microdomains of the plasma membrane. Eur J Biochem. 267:2483-97.
• 2. a. b. c. d. [367] Guzzi, F, Zanchetta D, Cassoni P, Guzzi V, Francolini M, Parenti M, Chini B.  2002.  Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response. Oncogene. 21:1658-67.
• 3. [437] Whittington, K, Connors B, King K, Assinder S, Hogarth K, Nicholson H.  2007.  The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate. Prostate. 67:1132-42.

HEK-293 1; MDCK 2

• 1. a. b. c. d. [362] Gimpl, G, Fahrenholz F.  2000.  Human oxytocin receptors in cholesterol-rich vs. cholesterol-poor microdomains of the plasma membrane. Eur J Biochem. 267:2483-97.
• 2. a. b. c. d. e. [367] Guzzi, F, Zanchetta D, Cassoni P, Guzzi V, Francolini M, Parenti M, Chini B.  2002.  Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response. Oncogene. 21:1658-67.
• 3. [437] Whittington, K, Connors B, King K, Assinder S, Hogarth K, Nicholson H.  2007.  The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate. Prostate. 67:1132-42.

Stable expression 1, 2

• 1. a. b. c. d. e. f. [362] Gimpl, G, Fahrenholz F.  2000.  Human oxytocin receptors in cholesterol-rich vs. cholesterol-poor microdomains of the plasma membrane. Eur J Biochem. 267:2483-97.
• 2. a. b. c. d. e. f. g. [367] Guzzi, F, Zanchetta D, Cassoni P, Guzzi V, Francolini M, Parenti M, Chini B.  2002.  Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response. Oncogene. 21:1658-67.
• 3. [437] Whittington, K, Connors B, King K, Assinder S, Hogarth K, Nicholson H.  2007.  The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate. Prostate. 67:1132-42.